Abstract
Objective
This study aims to investigate the association between adherence to the EAT-Lancet diet and the prevalence of sarcopenia as well as sarcopenic obesity in adults.
Methods
This study included 9672 participants from the National Health and Nutrition Examination Survey. We developed an EAT-Lancet score based on 24-hour dietary recall data and grouped the participants according to the quartiles of this score. Weighted multivariate logistic regression models and restricted cubic splines were employed to assess the association between the EAT-Lancet diet and sarcopenia and sarcopenic obesity. Additionally, mediation analysis was conducted to evaluate the mediating role of inflammatory biomarkers in this relationship.
Results
Among the 9672 participants, 910 (9.41%) were identified with sarcopenia, and 607 (6.28%) were identified with sarcopenic obesity. After adjusting for potential confounders, the odds ratios (OR) and 95% confidence intervals (CI) for sarcopenia and sarcopenic obesity in the highest quartile groups were 0.72 (0.54–0.95) and 0.58 (0.42–0.82), respectively, compared to those in the lowest quartile group. A 10-point increase in the EAT-Lancet diet score was significantly associated with a reduced risk of sarcopenia and sarcopenic obesity, with OR (95% CI) of 0.90 (0.84–0.98) and 0.86 (0.79–0.93), respectively. Furthermore, white blood cell count demonstrated the strongest mediating effect on this association, followed by C-reactive protein, systemic inflammation response index and systemic inflammatory index.
Conclusion
Our study indicated that adherence to the EAT-Lancet diet was associated with a lower risk of sarcopenia and sarcopenic obesity, with this association partially mediated by inflammatory biomarkers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
Data availability
The data supporting the findings of this study are openly available in: https://www.cdc.gov/nchs/nhanes/. The analysis code is publicly accessible on GitHub, and the specific link can be obtained from the corresponding author upon reasonable request.
References
Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393:2636–46.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.
Cao L, Morley JE. Sarcopenia is recognized as an independent condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. J Am Med Dir Assoc. 2016;17:675–7.
Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889–96.
Yeung SSY, Reijnierse EM, Pham VK, Trappenburg MC, Lim WK, Meskers CGM, et al. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2019;10:485–500.
Choi KM. Sarcopenia and sarcopenic obesity. Korean J Intern Med. 2016;31:1054–60.
Barazzoni R, Bischoff S, Boirie Y, Busetto L, Cederholm T, Dicker D, et al. Sarcopenic obesity: time to meet the challenge. Obes Facts. 2018;11:294–305.
Benz E, Pinel A, Guillet C, Capel F, Pereira B, De Antonio M, et al. Sarcopenia and sarcopenic obesity and mortality among older people. JAMA Netw Open. 2024;7:e243604.
Yuan S, Larsson SC. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023;144:155533.
Sieber CC. Malnutrition and sarcopenia. Aging Clin Exp Res. 2019;31:793–8.
Willett W, Rockström J, Loken B, Springmann M, Lang T, Vermeulen S, et al. Food in the anthropocene: the EAT-Lancet Commission on healthy diets from sustainable food systems. Lancet. 2019;393:447–92.
Zhang S, Stubbendorff A, Olsson K, Ericson U, Niu K, Qi L, et al. Adherence to the EAT-Lancet diet, genetic susceptibility, and risk of type 2 diabetes in Swedish adults. Metabolism. 2023;141:155401.
Sawicki CM, Ramesh G, Bui L, Nair NK, Hu FB, Rimm EB, et al. Planetary health diet and cardiovascular disease: results from three large prospective cohort studies in the USA. Lancet Planet Health. 2024;8:e666–74.
Bui LP, Pham TT, Wang F, Chai B, Sun Q, Hu FB, et al. Planetary Health Diet Index and risk of total and cause-specific mortality in three prospective cohorts. Am J Clin Nutr. 2024;120:80–91.
Chew STH, Tan NC, Cheong M, Oliver J, Baggs G, Choe Y, et al. Impact of specialized oral nutritional supplement on clinical, nutritional, and functional outcomes: a randomized, placebo-controlled trial in community-dwelling older adults at risk of malnutrition. Clin Nutr. 2021;40:1879–92.
Choi M, Kim H, Bae J. Does the combination of resistance training and a nutritional intervention have a synergic effect on muscle mass, strength, and physical function in older adults? A systematic review and meta-analysis. BMC Geriatr. 2021;21:639.
Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Vital Health Stat 1. 2013;56:1–37.
Ahluwalia N, Dwyer J, Terry A, Moshfegh A, Johnson C. Update on NHANES dietary data: focus on collection, release, analytical considerations, and uses to inform public policy. Adv Nutr. 2016;7:121–34.
Frank SM, Jaacks LM, Adair LS, Avery CL, Meyer K, Rose D, et al. Adherence to the Planetary Health Diet Index and correlation with nutrients of public health concern: an analysis of NHANES 2003-2018. Am J Clin Nutr. 2024;119:384–92.
Jiang C, Choi S, Gong H. From planetary health diet (PHD) to mental health: higher PHD index protects against depression among the U.S. population. J Psychiatr Res. 2025;183:31–38.
Bano G, Trevisan C, Carraro S, Solmi M, Luchini C, Stubbs B, et al. Inflammation and sarcopenia: a systematic review and meta-analysis. Maturitas. 2017;96:10–15.
Jimenez-Gutierrez GE, Martínez-Gómez LE, Martínez-Armenta C, Pineda C, Martínez-Nava GA, Lopez-Reyes A. Molecular mechanisms of inflammation in sarcopenia: diagnosis and therapeutic update. Cells. 2022;11:2359.
Guo B, Liu X, Si Q, Zhang D, Li M, Li X, et al. Associations of CBC-derived inflammatory indicators with sarcopenia and mortality in adults: evidence from Nhanes 1999 ∼ 2006. BMC Geriatr. 2024;24:432.
Xie S, Wu Q. Association between the systemic immune-inflammation index and sarcopenia: a systematic review and meta-analysis. J Orthop Surg Res. 2024;19:314.
Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69:547–58.
Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15:321–35.
Wang B, Wei Y, Shao L, Li M, Zhang X, Li W, et al. Association of dietary patterns and sarcopenia in the elderly population: a cross-sectional study. Front Aging. 2023;4:1239945.
Park Y, Choi JE, Hwang HS. Protein supplementation improves muscle mass and physical performance in undernourished prefrail and frail elderly subjects: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2018;108:1026–33.
Ganapathy A, Nieves JW. Nutrition and sarcopenia—what do we know?. Nutrients. 2020;12:1755.
Klapp R, Laxamana JA, Shvetsov YB, Park SY, Kanehara R, Setiawan VW, et al. The EAT-Lancet Diet Index is associated with lower obesity and incidence of type 2 diabetes in the multiethnic cohort. J Nutr. 2024;154:3407–15.
Zhu F, Du B, Xu B. Anti-inflammatory effects of phytochemicals from fruits, vegetables, and food legumes: a review. Crit Rev Food Sci Nutr. 2018;58:1260–70.
Koelman L, Herpich C, Norman K, Jannasch F, Börnhorst C, Schulze MB, et al. Adherence to healthy and sustainable dietary patterns and long-term chronic inflammation: data from the EPIC-Potsdam Cohort. J Nutr Health Aging. 2023;27:1109–17.
Liu F, Si C, Chen L, Peng Y, Wang P, Wang X, et al. EAT-Lancet diet pattern, genetic predisposition, inflammatory biomarkers, and risk of lung cancer incidence and mortality. Mol Nutr Food Res. 2024;68:e2400448.
Thomas DR. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr. 2007;26:389–99.
Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 2002;76:473–81.
Calvani R, Picca A, Coelho-Júnior HJ, Tosato M, Marzetti E, Landi F. Diet for the prevention and management of sarcopenia. Metabolism. 2023;146:155637.
Duan Y, Li F, Liu H, Li Y, Liu Y, Kong X, et al. Nutritional and regulatory roles of leucine in muscle growth and fat reduction. Front Biosci. 2015;20:796–813.
Hu FL, Liu JC, Li DR, Xu YL, Liu BQ, Chen X, et al. EAT-Lancet diet pattern, genetic risk, and risk of colorectal cancer: a prospective study from the UK Biobank. Am J Clin Nutr. 2025;121:1017–24.
Zhan J, Bui L, Hodge RA, Zimmer M, Pham T, Rose D, et al. Planetary Health Diet Index trends and associations with dietary greenhouse gas emissions, disease biomarkers, obesity, and mortality in the United States (2005-2018). Am J Clin Nutr. 2025;121:580–8.
Acknowledgements
We sincerely thank all the NHANES participants and staff for their valuable efforts.
Funding
ZHL was funded by the National Natural Science Foundation of China (No. 82200442), and Science and Technology Program of Guangzhou (No. 2025A04J3768).
Author information
Authors and Affiliations
Contributions
LHC, WBC and JBG were integral to the conception and design of this study. LHC, YSL, ZHL, JY and PL were involved in the acquisition, analysis, and interpretation of the data. LHC, YSL, ZHL, YS and WJ contributed to checking data, making charts and drafting the manuscript. All authors participated in reviewing, editing and providing approval for the final version of the manuscript. WBC and JBG assume the role of guarantors for this work, thereby possessing full access to all study data, shouldering responsibility for data integrity and ensuring the precision of data analysis.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
NHANES was approved by the Ethics Review Committee of the National Center for Health Statistics, and all participants have provided written informed consent upon enrollment.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chen, L., Liao, Y., Li, Z. et al. Association between adherence to EAT-Lancet diet and risk of sarcopenia and sarcopenic obesity in adults. Int J Obes 50, 229–237 (2026). https://doi.org/10.1038/s41366-025-01940-0
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41366-025-01940-0


